- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:58 | GSK departs Wave's AATD programme | ||
| 13:58 | FDA knocks back AstraZeneca's self-injected lupus drug | ||
| 12:58 | UK will cover transport costs for children with cancer | ||
| 11:58 | Novo Nordisk's CagriSema tops Ozempic in diabetes trial | ||
| 10:58 | GSK kicks out of Wave's AATD programme | ||
| Mo | UK body raps Sanofi for disparaging Pfizer's RSV jab | ||
| Mo | FDA knocks back Pharming's bid for wider Joenja use | ||
| Mo | Mixed data mars Sanofi's venglustat programme | ||
| Mo | Mixed data mar Sanofi's venglustat programme | ||
| Mo | FDA launches pilot programme to boost US manufacturing | ||
| Mo | UCB bags first EU approval for rare genetic disease TK2d | ||
| Mo | Lilly names Pennsylvania site for its latest US facility | ||
| Fr | EMA looks into 'data integrity' issue with Amgen's Tavneos | ||
| Fr | FDA starts review of Summit's VEGFxPD-1 bispecific | ||
| Fr | Three more biotechs price their Nasdaq IPOs | ||
| Fr | GLP-1 drugs linked to pancreatitis, gallbladder problems | ||
| Fr | AstraZeneca deepens Chinese ties, signs $18.5bn CSPC Pharma obesity deal | ||
| Do | Tenpoint eyes presbyopia drug launch after FDA nod | ||
| Do | Digital musculoskeletal care firm Sword buys rival Kaia | ||
| Do | Otsuka preps for July decision on centanafadine for ADHD | ||
| Mi | Halozyme diversifies in drug delivery with Surf Bio buy | ||
| Mi | Eikon prices its IPO, seeking to raise $318m | ||
| Mi | Lilly allies with gene-editing firm Seamless on hearing loss | ||
| Mi | Boehringer drug scores in rare kidney disease FSGS | ||
| Mi | CMS's Medicare price negotiations start round three |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.